irinotecan has been researched along with metallothionein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JM; Chang, HJ; Choi, IJ; Chun, JH; Kang, HC; Kim, E; Kim, HK; Kim, IH; Kim, IJ; Kim, JH; Lim, HS; Park, JG; Park, JH | 1 |
1 other study(ies) available for irinotecan and metallothionein
| Article | Year |
|---|---|
Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Male; Metallothionein; Middle Aged; Oligonucleotide Array Sequence Analysis; Stomach Neoplasms | 2004 |